Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein

S Hegewisch-Becker1, C Faltz, D K Hossfeld

  • 1Department of Oncology and Hematology, Medical University Clinic of Hamburg, Germany.

European Journal of Haematology
|January 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Cytogenetic Studies in Patients with Acute Myeloid Leukemia Following a Myelodysplastic Syndrome.

Leukemia & lymphoma·2016
Same author

Immunophenotype of Abnormal Metaphases Demonstrating Multilineage Involvement in Myelodysplastic Syndromes.

Leukemia & lymphoma·2016
Same author

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108.

European journal of cancer (Oxford, England : 1990)·2016

Daunorubicin accumulation studies predict acute leukaemia treatment response. Stringent conditions enhance accuracy, outperforming P-glycoprotein detection for predicting chemotherapy outcomes in patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Pharmacology

Background:

  • Multidrug resistance (MDR1) gene product P-glycoprotein (P-gp) detection via daunorubicin (DNR) accumulation studies shows varied correlation with chemotherapy response in acute leukaemia.
  • Divergent results may stem from experimental conditions affecting P-gp function and drug accumulation.
  • Investigating factors influencing DNR accumulation is crucial for reliable P-gp functional assays in clinical settings.

Purpose of the Study:

  • To investigate the impact of experimental conditions, specifically medium exchange duration, on daunorubicin (DNR) accumulation in a multidrug resistant cell line (CEM/VBL100).
  • To evaluate the reliability of DNR accumulation as a functional test for P-glycoprotein (P-gp) in predicting treatment response in acute leukaemia patients.
  • To compare DNR accumulation assay with immunocytochemistry for P-gp detection in clinical samples.

Related Experiment Videos

Main Methods:

  • Daunorubicin (DNR) accumulation was measured using flow cytometry in the CEM/VBL100 cell line under standard and prolonged medium exchange conditions (42 hours).
  • Verapamil (10 µmol/l) was used to assess P-gp inhibition and enhance DNR accumulation.
  • 53 acute leukaemia patient samples (ALL-18, AML-37) were analyzed for DNR accumulation with Verapamil or Cyclosporin A (3 µmol/l) under stringent, rapid processing conditions.

Main Results:

  • Prolonging medium exchange by 30 hours (to 42 hours) significantly reduced the Verapamil-induced increase in DNR accumulation from 90% to 26% in the cell line.
  • This reduction in DNR accumulation was not linked to changes in MDR1 gene expression at RNA or protein levels.
  • In newly diagnosed leukaemia patients, DNR accumulation enhancement (>20% with inhibitors) correlated significantly with treatment response (p=0.002), outperforming immunocytochemistry (p=0.03).

Conclusions:

  • Experimental conditions, particularly medium handling, critically affect daunorubicin accumulation assays for P-glycoprotein function.
  • Daunorubicin accumulation studies, when performed meticulously under stringent conditions, serve as a sensitive predictor of therapy outcome in acute leukaemia.
  • This functional assay offers a more reliable prediction of chemotherapy response compared to static P-gp detection methods in acute leukaemia.